Evidence map›Paper›PMID 33762689›Full record

Trial reportPediatric research2022

Early probiotic supplementation with B. infantis in breastfed infants leads to persistent colonization at 1 year.

Claire E O'Brien, Anna K Meier, Karina Cernioglo, Ryan D Mitchell, Giorgio Casaburi, Steven A Frese, Bethany M Henrick, Mark A Underwood, Jennifer T Smilowitz

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Pediatric research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Review
  8. Article
  9. mSphere · 2026
    Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Claire E O'BrienDepartment of Food Science and Technology, University of California Davis, Davis, CA, USA.
Anna K MeierDepartment of Food Science and Technology, University of California Davis, Davis, CA, USA.
Karina CerniogloDepartment of Food Science and Technology, University of California Davis, Davis, CA, USA.
Ryan D MitchellEvolve BioSystems, Inc., Davis, CA, USA.
Giorgio CasaburiPrescient Metabiomics, 600 Faraday Ave, Carlsbad, CA, 92008, USA.
Steven A FreseDepartment of Nutrition, University of Nevada, Reno, Reno, NV, 89557, USA.
Bethany M HenrickEvolve BioSystems, Inc., Davis, CA, USA.
Mark A UnderwoodDepartment of Pediatrics, University of California Davis Children's Hospital, Sacramento, CA, USA.
Jennifer T SmilowitzDepartment of Food Science and Technology, University of California Davis, Davis, CA, USA. jensm@ucdavis.edu.

Funding

ENVIRONMENTAL TOXICOLOGYT32ES007059 · NIEHS · UNIVERSITY OF CALIFORNIA DAVIS · PI Laura S Van Winkle · 1985 to 2026
$7.9M
NIEHS NIH HHS T32 ES007059
6 · The paper itself

Abstract

backgroundRecent studies have reported a dysfunctional gut microbiome in breastfed infants. Probiotics have been used in an attempt to restore the gut microbiome; however, colonization has been transient, inconsistent among individuals, or has not positively impacted the host's gut.

methodsThis is a 2-year follow-up study to a randomized controlled trial wherein 7-day-old infants received 1.8 × 10

resultsFecal B. infantis was 2.5-3.5 log units higher at 6-12 months in the EVC group compared with the UNS group (P < 0.01) and this relationship strengthened with the exclusion of infants who consumed infant formula and antibiotics. Infants in the EVC group had significantly higher Bifidobacteriaceae and lower Bacteroidaceae and Lachnospiraceae (P < 0.05). There were no differences in any health conditions between the two groups.

conclusionsProbiotic supplementation with B. infantis within the first month postnatal, in combination with breast milk, resulted in stable colonization that persisted until at least 1 year postnatal. IMPACT: A dysfunctional gut microbiome in breastfed infants is common in resource-rich nations and associated with an increased risk of immune diseases. Probiotics only transiently exist in the gut without persistent colonization or altering the gut microbiome. This is the first study to show that early probiotic supplementation with B. infantis with breast milk results in stable colonization of B. infantis and improvements to the gut microbiome 1 year postnatal. This study addresses a key gap in the literature whereby probiotics can restore the gut microbiome if biologically selected microorganisms are matched with their specific food in an open ecological niche.

Indexed as

Gastrointestinal MicrobiomeProbioticsBifidobacterium longum subspecies infantisBreast FeedingFecesFemaleFollow-Up StudiesHumansInfantMilk, Human

Identifiers

PMID33762689
PMCPMC8460680

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.